01 1Quimica Sintetica S.A.
02 1UQUIFA Mexico, S.A. DE C.V.
01 1CIPROFLOXACIN
02 1Ciprofloxacin
01 2Spain
NDC Package Code : 53069-0680
Start Marketing Date : 2002-03-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52286-0014
Start Marketing Date : 2009-11-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
34
PharmaCompass offers a list of Ciprofloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ciprofloxacin manufacturer or Ciprofloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ciprofloxacin manufacturer or Ciprofloxacin supplier.
PharmaCompass also assists you with knowing the Ciprofloxacin API Price utilized in the formulation of products. Ciprofloxacin API Price is not always fixed or binding as the Ciprofloxacin Price is obtained through a variety of data sources. The Ciprofloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Proksi 500 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Proksi 500, including repackagers and relabelers. The FDA regulates Proksi 500 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Proksi 500 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Proksi 500 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Proksi 500 supplier is an individual or a company that provides Proksi 500 active pharmaceutical ingredient (API) or Proksi 500 finished formulations upon request. The Proksi 500 suppliers may include Proksi 500 API manufacturers, exporters, distributors and traders.
click here to find a list of Proksi 500 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Proksi 500 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Proksi 500 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Proksi 500 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Proksi 500 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Proksi 500 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Proksi 500 suppliers with NDC on PharmaCompass.
We have 2 companies offering Proksi 500
Get in contact with the supplier of your choice:
